Diabetic Foot Ulcer Therapeutic Market, Global Outlook and Forecast 2022-2028

March 2022 | 65 pages | ID: D5AEFF3A3874EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Diabetic Foot Ulcer Therapeutic in Global, including the following market information:

Global Diabetic Foot Ulcer Therapeutic Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Diabetic Foot Ulcer Therapeutic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Advance Wound Dressings Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Diabetic Foot Ulcer Therapeutic include B. Braun Melsungen AG, Smith & Nephew, Inc., Organogenesis, Inc., Derma Sciences Inc., Sigvaris Inc., 3M, Acelity L.P. Inc., Innocoll Holdings plc. and SIGVARIS, Inc.. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Diabetic Foot Ulcer Therapeutic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Diabetic Foot Ulcer Therapeutic Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Diabetic Foot Ulcer Therapeutic Market Segment Percentages, by Type, 2021 (%)

• Advance Wound Dressings
• Skin Substitutes
• Negative Pressure Wound Therapy Devices

Global Diabetic Foot Ulcer Therapeutic Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Diabetic Foot Ulcer Therapeutic Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Specialty Clinics
• Long-Term Care Centers
• Ambulatory Surgical Centers

Global Diabetic Foot Ulcer Therapeutic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Diabetic Foot Ulcer Therapeutic Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Diabetic Foot Ulcer Therapeutic revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Diabetic Foot Ulcer Therapeutic revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• B. Braun Melsungen AG
• Smith & Nephew, Inc.
• Organogenesis, Inc.
• Derma Sciences Inc.
• Sigvaris Inc.
• 3M
• Acelity L.P. Inc.
• Innocoll Holdings plc.
• SIGVARIS, Inc.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Diabetic Foot Ulcer Therapeutic Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Diabetic Foot Ulcer Therapeutic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL DIABETIC FOOT ULCER THERAPEUTIC OVERALL MARKET SIZE

2.1 Global Diabetic Foot Ulcer Therapeutic Market Size: 2021 VS 2028
2.2 Global Diabetic Foot Ulcer Therapeutic Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Diabetic Foot Ulcer Therapeutic Players in Global Market
3.2 Top Global Diabetic Foot Ulcer Therapeutic Companies Ranked by Revenue
3.3 Global Diabetic Foot Ulcer Therapeutic Revenue by Companies
3.4 Top 3 and Top 5 Diabetic Foot Ulcer Therapeutic Companies in Global Market, by Revenue in 2021
3.5 Global Companies Diabetic Foot Ulcer Therapeutic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Diabetic Foot Ulcer Therapeutic Players in Global Market
  3.6.1 List of Global Tier 1 Diabetic Foot Ulcer Therapeutic Companies
  3.6.2 List of Global Tier 2 and Tier 3 Diabetic Foot Ulcer Therapeutic Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Diabetic Foot Ulcer Therapeutic Market Size Markets, 2021 & 2028
  4.1.2 Advance Wound Dressings
  4.1.3 Skin Substitutes
  4.1.4 Negative Pressure Wound Therapy Devices
4.2 By Type - Global Diabetic Foot Ulcer Therapeutic Revenue & Forecasts
  4.2.1 By Type - Global Diabetic Foot Ulcer Therapeutic Revenue, 2017-2022
  4.2.2 By Type - Global Diabetic Foot Ulcer Therapeutic Revenue, 2023-2028
  4.2.3 By Type - Global Diabetic Foot Ulcer Therapeutic Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Diabetic Foot Ulcer Therapeutic Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Specialty Clinics
  5.1.4 Long-Term Care Centers
  5.1.5 Ambulatory Surgical Centers
5.2 By Application - Global Diabetic Foot Ulcer Therapeutic Revenue & Forecasts
  5.2.1 By Application - Global Diabetic Foot Ulcer Therapeutic Revenue, 2017-2022
  5.2.2 By Application - Global Diabetic Foot Ulcer Therapeutic Revenue, 2023-2028
  5.2.3 By Application - Global Diabetic Foot Ulcer Therapeutic Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Diabetic Foot Ulcer Therapeutic Market Size, 2021 & 2028
6.2 By Region - Global Diabetic Foot Ulcer Therapeutic Revenue & Forecasts
  6.2.1 By Region - Global Diabetic Foot Ulcer Therapeutic Revenue, 2017-2022
  6.2.2 By Region - Global Diabetic Foot Ulcer Therapeutic Revenue, 2023-2028
  6.2.3 By Region - Global Diabetic Foot Ulcer Therapeutic Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Diabetic Foot Ulcer Therapeutic Revenue, 2017-2028
  6.3.2 US Diabetic Foot Ulcer Therapeutic Market Size, 2017-2028
  6.3.3 Canada Diabetic Foot Ulcer Therapeutic Market Size, 2017-2028
  6.3.4 Mexico Diabetic Foot Ulcer Therapeutic Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Diabetic Foot Ulcer Therapeutic Revenue, 2017-2028
  6.4.2 Germany Diabetic Foot Ulcer Therapeutic Market Size, 2017-2028
  6.4.3 France Diabetic Foot Ulcer Therapeutic Market Size, 2017-2028
  6.4.4 U.K. Diabetic Foot Ulcer Therapeutic Market Size, 2017-2028
  6.4.5 Italy Diabetic Foot Ulcer Therapeutic Market Size, 2017-2028
  6.4.6 Russia Diabetic Foot Ulcer Therapeutic Market Size, 2017-2028
  6.4.7 Nordic Countries Diabetic Foot Ulcer Therapeutic Market Size, 2017-2028
  6.4.8 Benelux Diabetic Foot Ulcer Therapeutic Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Diabetic Foot Ulcer Therapeutic Revenue, 2017-2028
  6.5.2 China Diabetic Foot Ulcer Therapeutic Market Size, 2017-2028
  6.5.3 Japan Diabetic Foot Ulcer Therapeutic Market Size, 2017-2028
  6.5.4 South Korea Diabetic Foot Ulcer Therapeutic Market Size, 2017-2028
  6.5.5 Southeast Asia Diabetic Foot Ulcer Therapeutic Market Size, 2017-2028
  6.5.6 India Diabetic Foot Ulcer Therapeutic Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Diabetic Foot Ulcer Therapeutic Revenue, 2017-2028
  6.6.2 Brazil Diabetic Foot Ulcer Therapeutic Market Size, 2017-2028
  6.6.3 Argentina Diabetic Foot Ulcer Therapeutic Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Diabetic Foot Ulcer Therapeutic Revenue, 2017-2028
  6.7.2 Turkey Diabetic Foot Ulcer Therapeutic Market Size, 2017-2028
  6.7.3 Israel Diabetic Foot Ulcer Therapeutic Market Size, 2017-2028
  6.7.4 Saudi Arabia Diabetic Foot Ulcer Therapeutic Market Size, 2017-2028
  6.7.5 UAE Diabetic Foot Ulcer Therapeutic Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 B. Braun Melsungen AG
  7.1.1 B. Braun Melsungen AG Corporate Summary
  7.1.2 B. Braun Melsungen AG Business Overview
  7.1.3 B. Braun Melsungen AG Diabetic Foot Ulcer Therapeutic Major Product Offerings
  7.1.4 B. Braun Melsungen AG Diabetic Foot Ulcer Therapeutic Revenue in Global Market (2017-2022)
  7.1.5 B. Braun Melsungen AG Key News
7.2 Smith & Nephew, Inc.
  7.2.1 Smith & Nephew, Inc. Corporate Summary
  7.2.2 Smith & Nephew, Inc. Business Overview
  7.2.3 Smith & Nephew, Inc. Diabetic Foot Ulcer Therapeutic Major Product Offerings
  7.2.4 Smith & Nephew, Inc. Diabetic Foot Ulcer Therapeutic Revenue in Global Market (2017-2022)
  7.2.5 Smith & Nephew, Inc. Key News
7.3 Organogenesis, Inc.
  7.3.1 Organogenesis, Inc. Corporate Summary
  7.3.2 Organogenesis, Inc. Business Overview
  7.3.3 Organogenesis, Inc. Diabetic Foot Ulcer Therapeutic Major Product Offerings
  7.3.4 Organogenesis, Inc. Diabetic Foot Ulcer Therapeutic Revenue in Global Market (2017-2022)
  7.3.5 Organogenesis, Inc. Key News
7.4 Derma Sciences Inc.
  7.4.1 Derma Sciences Inc. Corporate Summary
  7.4.2 Derma Sciences Inc. Business Overview
  7.4.3 Derma Sciences Inc. Diabetic Foot Ulcer Therapeutic Major Product Offerings
  7.4.4 Derma Sciences Inc. Diabetic Foot Ulcer Therapeutic Revenue in Global Market (2017-2022)
  7.4.5 Derma Sciences Inc. Key News
7.5 Sigvaris Inc.
  7.5.1 Sigvaris Inc. Corporate Summary
  7.5.2 Sigvaris Inc. Business Overview
  7.5.3 Sigvaris Inc. Diabetic Foot Ulcer Therapeutic Major Product Offerings
  7.5.4 Sigvaris Inc. Diabetic Foot Ulcer Therapeutic Revenue in Global Market (2017-2022)
  7.5.5 Sigvaris Inc. Key News
7.6 3M
  7.6.1 3M Corporate Summary
  7.6.2 3M Business Overview
  7.6.3 3M Diabetic Foot Ulcer Therapeutic Major Product Offerings
  7.6.4 3M Diabetic Foot Ulcer Therapeutic Revenue in Global Market (2017-2022)
  7.6.5 3M Key News
7.7 Acelity L.P. Inc.
  7.7.1 Acelity L.P. Inc. Corporate Summary
  7.7.2 Acelity L.P. Inc. Business Overview
  7.7.3 Acelity L.P. Inc. Diabetic Foot Ulcer Therapeutic Major Product Offerings
  7.7.4 Acelity L.P. Inc. Diabetic Foot Ulcer Therapeutic Revenue in Global Market (2017-2022)
  7.7.5 Acelity L.P. Inc. Key News
7.8 Innocoll Holdings plc.
  7.8.1 Innocoll Holdings plc. Corporate Summary
  7.8.2 Innocoll Holdings plc. Business Overview
  7.8.3 Innocoll Holdings plc. Diabetic Foot Ulcer Therapeutic Major Product Offerings
  7.8.4 Innocoll Holdings plc. Diabetic Foot Ulcer Therapeutic Revenue in Global Market (2017-2022)
  7.8.5 Innocoll Holdings plc. Key News
7.9 SIGVARIS, Inc.
  7.9.1 SIGVARIS, Inc. Corporate Summary
  7.9.2 SIGVARIS, Inc. Business Overview
  7.9.3 SIGVARIS, Inc. Diabetic Foot Ulcer Therapeutic Major Product Offerings
  7.9.4 SIGVARIS, Inc. Diabetic Foot Ulcer Therapeutic Revenue in Global Market (2017-2022)
  7.9.5 SIGVARIS, Inc. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Diabetic Foot Ulcer Therapeutic Market Opportunities & Trends in Global Market
Table 2. Diabetic Foot Ulcer Therapeutic Market Drivers in Global Market
Table 3. Diabetic Foot Ulcer Therapeutic Market Restraints in Global Market
Table 4. Key Players of Diabetic Foot Ulcer Therapeutic in Global Market
Table 5. Top Diabetic Foot Ulcer Therapeutic Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Diabetic Foot Ulcer Therapeutic Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Diabetic Foot Ulcer Therapeutic Revenue Share by Companies, 2017-2022
Table 8. Global Companies Diabetic Foot Ulcer Therapeutic Product Type
Table 9. List of Global Tier 1 Diabetic Foot Ulcer Therapeutic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Diabetic Foot Ulcer Therapeutic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Diabetic Foot Ulcer Therapeutic Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Diabetic Foot Ulcer Therapeutic Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Diabetic Foot Ulcer Therapeutic Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Diabetic Foot Ulcer Therapeutic Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Diabetic Foot Ulcer Therapeutic Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Diabetic Foot Ulcer Therapeutic Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Diabetic Foot Ulcer Therapeutic Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Diabetic Foot Ulcer Therapeutic Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Diabetic Foot Ulcer Therapeutic Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Diabetic Foot Ulcer Therapeutic Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Diabetic Foot Ulcer Therapeutic Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Diabetic Foot Ulcer Therapeutic Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Diabetic Foot Ulcer Therapeutic Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Diabetic Foot Ulcer Therapeutic Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Diabetic Foot Ulcer Therapeutic Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Diabetic Foot Ulcer Therapeutic Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Diabetic Foot Ulcer Therapeutic Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Diabetic Foot Ulcer Therapeutic Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Diabetic Foot Ulcer Therapeutic Revenue, (US$, Mn), 2023-2028
Table 30. B. Braun Melsungen AG Corporate Summary
Table 31. B. Braun Melsungen AG Diabetic Foot Ulcer Therapeutic Product Offerings
Table 32. B. Braun Melsungen AG Diabetic Foot Ulcer Therapeutic Revenue (US$, Mn), (2017-2022)
Table 33. Smith & Nephew, Inc. Corporate Summary
Table 34. Smith & Nephew, Inc. Diabetic Foot Ulcer Therapeutic Product Offerings
Table 35. Smith & Nephew, Inc. Diabetic Foot Ulcer Therapeutic Revenue (US$, Mn), (2017-2022)
Table 36. Organogenesis, Inc. Corporate Summary
Table 37. Organogenesis, Inc. Diabetic Foot Ulcer Therapeutic Product Offerings
Table 38. Organogenesis, Inc. Diabetic Foot Ulcer Therapeutic Revenue (US$, Mn), (2017-2022)
Table 39. Derma Sciences Inc. Corporate Summary
Table 40. Derma Sciences Inc. Diabetic Foot Ulcer Therapeutic Product Offerings
Table 41. Derma Sciences Inc. Diabetic Foot Ulcer Therapeutic Revenue (US$, Mn), (2017-2022)
Table 42. Sigvaris Inc. Corporate Summary
Table 43. Sigvaris Inc. Diabetic Foot Ulcer Therapeutic Product Offerings
Table 44. Sigvaris Inc. Diabetic Foot Ulcer Therapeutic Revenue (US$, Mn), (2017-2022)
Table 45. 3M Corporate Summary
Table 46. 3M Diabetic Foot Ulcer Therapeutic Product Offerings
Table 47. 3M Diabetic Foot Ulcer Therapeutic Revenue (US$, Mn), (2017-2022)
Table 48. Acelity L.P. Inc. Corporate Summary
Table 49. Acelity L.P. Inc. Diabetic Foot Ulcer Therapeutic Product Offerings
Table 50. Acelity L.P. Inc. Diabetic Foot Ulcer Therapeutic Revenue (US$, Mn), (2017-2022)
Table 51. Innocoll Holdings plc. Corporate Summary
Table 52. Innocoll Holdings plc. Diabetic Foot Ulcer Therapeutic Product Offerings
Table 53. Innocoll Holdings plc. Diabetic Foot Ulcer Therapeutic Revenue (US$, Mn), (2017-2022)
Table 54. SIGVARIS, Inc. Corporate Summary
Table 55. SIGVARIS, Inc. Diabetic Foot Ulcer Therapeutic Product Offerings
Table 56. SIGVARIS, Inc. Diabetic Foot Ulcer Therapeutic Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Diabetic Foot Ulcer Therapeutic Segment by Type in 2021
Figure 2. Diabetic Foot Ulcer Therapeutic Segment by Application in 2021
Figure 3. Global Diabetic Foot Ulcer Therapeutic Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Diabetic Foot Ulcer Therapeutic Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Diabetic Foot Ulcer Therapeutic Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Diabetic Foot Ulcer Therapeutic Revenue in 2021
Figure 8. By Type - Global Diabetic Foot Ulcer Therapeutic Revenue Market Share, 2017-2028
Figure 9. By Application - Global Diabetic Foot Ulcer Therapeutic Revenue Market Share, 2017-2028
Figure 10. By Region - Global Diabetic Foot Ulcer Therapeutic Revenue Market Share, 2017-2028
Figure 11. By Country - North America Diabetic Foot Ulcer Therapeutic Revenue Market Share, 2017-2028
Figure 12. US Diabetic Foot Ulcer Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Diabetic Foot Ulcer Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Diabetic Foot Ulcer Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Diabetic Foot Ulcer Therapeutic Revenue Market Share, 2017-2028
Figure 16. Germany Diabetic Foot Ulcer Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 17. France Diabetic Foot Ulcer Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Diabetic Foot Ulcer Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Diabetic Foot Ulcer Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Diabetic Foot Ulcer Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Diabetic Foot Ulcer Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Diabetic Foot Ulcer Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Diabetic Foot Ulcer Therapeutic Revenue Market Share, 2017-2028
Figure 24. China Diabetic Foot Ulcer Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Diabetic Foot Ulcer Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Diabetic Foot Ulcer Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Diabetic Foot Ulcer Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 28. India Diabetic Foot Ulcer Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Diabetic Foot Ulcer Therapeutic Revenue Market Share, 2017-2028
Figure 30. Brazil Diabetic Foot Ulcer Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Diabetic Foot Ulcer Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Diabetic Foot Ulcer Therapeutic Revenue Market Share, 2017-2028
Figure 33. Turkey Diabetic Foot Ulcer Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Diabetic Foot Ulcer Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Diabetic Foot Ulcer Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Diabetic Foot Ulcer Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 37. B. Braun Melsungen AG Diabetic Foot Ulcer Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Smith & Nephew, Inc. Diabetic Foot Ulcer Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Organogenesis, Inc. Diabetic Foot Ulcer Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Derma Sciences Inc. Diabetic Foot Ulcer Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sigvaris Inc. Diabetic Foot Ulcer Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. 3M Diabetic Foot Ulcer Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Acelity L.P. Inc. Diabetic Foot Ulcer Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Innocoll Holdings plc. Diabetic Foot Ulcer Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. SIGVARIS, Inc. Diabetic Foot Ulcer Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)